Trade Summary

3 days ago, Garg Pushkal, serving as EVP Chief R, D at Alnylam Pharmaceuticals, Inc. (ALNY), sold 3,492 shares at $323.63 per share, for a total transaction value of $1,130,131.00. Following this transaction, Garg Pushkal now holds 24,087 shares of ALNY.

This sale represents a 13.00% decrease in Garg Pushkal's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Alnylam Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.